how i see it
control groups are either standard of care or placebo.
hyaluronic acid is not the current standard of care. it is experimental.
msb is developing a new experimental therapy using cells with HA.
they have done their research and it was found
benefits of cells plus HA, over cells alone in our phase 3 results.
benefit of cells vs HA alone, from phase 2. fda agrees
this article is informative on the potential for msc and other compositions with HA for disc disease![]()
- Forums
- ASX - By Stock
- MSB
- MSB 2022 - The road to commercialisation
MSB
mesoblast limited
Add to My Watchlist
1.71%
!
$2.30

MSB 2022 - The road to commercialisation, page-671
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.30 |
Change
-0.040(1.71%) |
Mkt cap ! $2.943B |
Open | High | Low | Value | Volume |
$2.32 | $2.36 | $2.30 | $6.598M | 2.848M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 47739 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 28495 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 47739 | 2.300 |
6 | 15383 | 2.290 |
5 | 45370 | 2.280 |
2 | 18849 | 2.260 |
8 | 61166 | 2.250 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 15942 | 2 |
2.330 | 35161 | 1 |
2.340 | 62193 | 8 |
2.350 | 8020 | 3 |
2.360 | 26801 | 7 |
Last trade - 16.10pm 17/09/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |